Abstract
Breast cancer is the most common and fatal malignant tumor in women, which causes great social burden throughout the world. At present, chemotherapy is still the most important treatment manner of advanced breast cancer, and platinum drugs are one of the commonly used chemotherapeutic drugs. Based on the substantial evidence, the expert committee deeply discusses the clinical application of platinum drugs in advanced breast cancer, gives the reasonable suggestions for its clinical usage, effectiveness and adverse effects. This consensus aims to guide physicians to use drugs reasonably and standardize the diagnosis and treatment.
| Translated title of the contribution | Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version) |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 97-105 |
| Number of pages | 9 |
| Journal | Clinical Medicine of China |
| Volume | 37 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver